Haemostasis

Handbook of Experimental Pharmacology

Volumn 176, Issue PART2, 2006, Pages 1-41

  Arnout, J ^a   Hoylaerts, M F ^a   Lijnen, H R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bleeding; Coagulation; Fibrinolysis; Haemostasis; Platelets; Thrombosis

Indexed keywords

EID: 34547542722     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/3-540-36028-x_1     Document Type: Article

References (190)

1. Abbracchio MP, Burnstock G (1994) Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64:445-475 (Pubitemid 24381231)
2. Andrews RK, Munday AD, Mitchell CA, Berndt MC (2001) Interaction of calmodulin with the cytoplasmic domain of the platelet membrane glycoprotein Ib-IX-V complex. Blood 98:681-687
3. Andrews RK, Suzuki-Inoue K, Shen Y, Tulasne D,Watson SP, BerndtMC (2002) Interaction of calmodulin with the cytoplasmic domain of platelet glycoprotein VI. Blood 99:4219-4221 (Pubitemid 35332069)
4. Annamalai AE, Stewart GJ,Hansel B, et al (1986) Expression of factor V on human umbilical vein endothelial cells is modulated by cell injury. Arteriosclerosis 6:196-202 (Pubitemid 16024129)
5. Bach R, Rifkin DB (1990) Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc Natl Acad Sci USA 87:6995-6999
6. BalasubramanianV,Grabowski E,Bini A,NemersonY(2002) Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 100:2787-27892
7. Bastida E, Escolar G, Ordinas A, Sixma JJ (1987) Fibronectin is required for platelet adhesion and for thrombus formation on subendothelium and collagen surfaces. Blood 70:1437-1442 (Pubitemid 18026151)
8. Beresford CH, Owen MC (1990) Antithrombin III. Int J Biochem 22:121-128 (Pubitemid 20120032)
9. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD (eds) (1994) Haemostasis and thrombosis, 3rd edn. Churchill Livingstone, Edinburgh
10. Bolhuis PA, Sakariassen KS, Sander HJ, Bouma BN, Sixma JJ (1981) Binding of factor VIIIvon Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med 97:568-576 (Pubitemid 11101220)
11. Bombeli T,MuellerM, Haeberli A (1997) Anticoagulant properties of the vascular endothelium. Thromb Haemost 77:408-423 (Pubitemid 27121001)
12. Bonnefoy A, Yamamoto H, Thys C, Kito M, Vermylen J, Hoylaerts MF (2003) Shielding the front-strand beta 3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibalpha. Blood 101:1375-1383 (Pubitemid 36182509)
13. Bosmans JM, Kockx MM, Vrints CJ, Bult H, De Meyer GR, Herman AG (1997) Fibrin(ogen) andvonWillebrand factor depositionare associatedwith intimal thickening afterballoon angioplasty of the rabbit carotid artery. Arterioscler Thromb Vasc Biol 17:634-645 (Pubitemid 27169123)
14. Broze Jr. G.J. (1995a) Tissue factor pathway inhibitor. Thromb Haemost 74:90-93
15. Broze Jr. G.J. (1995b) Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 46:103-112
16. Broze GJ Jr, Girard TJ, Novotny WF (1990) Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 29:7539-7546 (Pubitemid 20279168)
17. Bu G, Williams S, Strickland DK, Schwartz AL (1992) Low density lipoprotein receptorrelated protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 89:7427-7431
18. Bugge TH, Xiao Q, Kombrinck KW, et al (1996) Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiation of blood coagulation. Proc Natl Acad Sci USA 93:6258-6263
19. Burnstock G, Cocks T, Kasakov L, Wong HK (1978) Direct evidence for ATP release from non-adrenergic, non-cholinergic ("purinergic") nerves in the guinea-pig taenia coli and bladder. Eur J Pharmacol 49:145-149 (Pubitemid 9211618)
20. Butenas S, van 't Veer C, Mann KG (1997) Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 272:21527-21533 (Pubitemid 27374027)
21. Carmeliet P, Mackman N, Moons L, et al (1996) Role of tissue factor in embryonic blood vessel development. Nature 383:73-75 (Pubitemid 26296462)
22. Carmeliet P,Moons L, Stassen JM, DeMolM, Bouché A, van den Oord JJ, Kockx M, Collen D (1997a) Vascular wound healing and neointima formation induced by perivascular electric injury in mice. Am J Pathol 150:761-776 (Pubitemid 27073802)
23. Carmeliet P, Moons L, Ploplis V, Plow E, Collen D (1997b) Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 99:200-208 (Pubitemid 27053462)
24. Carmeliet P,Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D (1997c) Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice. Circ Res 81:829-839 (Pubitemid 27467218)
25. Carmeliet P,Moons L, Lijnen R, Janssens S, Lupu F, Collen D, Gerard RD (1997d) Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation. A gene targeting and gene transfer study in mice. Circulation 96:3180-3191 (Pubitemid 27500124)
26. Carmeliet P, Moons L, Dewerchin M, Rosenberg S, Herbert JM, Lupu F, Collen D (1998) Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. J Cell Biol 140:233-245 (Pubitemid 28070910)
27. Cattaneo M, Lombardi R, Zighetti ML, Gachet C, Ohlmann P, Cazenave JP, Mannucci PM (1997) Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production. Thromb Haemost 77:986-990 (Pubitemid 27239127)
28. CauwenberghsN,VanhoorelbekeK, VauterinS,WestraDF,RomoG,HuizingaEG, Lopez JA, Berndt MC, Harsfalvi J, Deckmyn H (2001) Epitope mapping of inhibitory antibodies against platelet glycoprotein Ibalpha reveals interaction between the leucine-rich repeat N-terminal and C-terminal flanking domains of glycoprotein Ibalpha. Blood 98:652-660
29. Celikel R, Varughese KI, Madhusudan, Yoshioka A, Ware J, Ruggeri ZM (1998) Crystal structure of the vonWillebrand factor A1 domain in complex with the function blocking NMC-4 Fab. Nat Struct Biol 5:189-194 (Pubitemid 28113749)
30. COBALT Investigators (1997)Acomparison of continuous infusion of alteplasewith doublebolus administration for acute myocardial infarction. N Engl J Med 337:1124-1130
31. CollenD, LijnenHR(1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78:3114-3124
32. Collen D, Lijnen HR (2003) Novel thrombolytic agents for treatment of acute myocardial infarction. InArnout J,deGaetanoG,HoylaertsM,PeerlinckK, VanGeetC,VerhaegheR (eds) Thrombosis. Fundamental and clinical aspects. Leuven University Press, Leuven, pp 585-596
33. Colman RW, Hirsh J, Marder VJ, Salzman E (eds) (1994) Hemostasis and thrombosis: basic principles and clinical practice, 3rd edn. JB Lippincott, Philadelphia
34. Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM (2000) Advances in signalling by extracellular nucleotides. The role and transduction mechanisms of P2Y receptors. Cell Signal 12:351-360 (Pubitemid 30417597)
35. Contrino J, Goralnick S, Qi J, et al (1997) Fibrin induction of tissue factor expression in human vascular endothelial cells. Circulation 96:605-613 (Pubitemid 27329441)
36. Cruz MA, Diacovo TG, Emsley J, Liddington R, Handin RI (2000)Mapping the glycoprotein Ib-binding site in the vonWillebrand factor A1 domain. J Biol Chem 275:19098-19105 (Pubitemid 30422878)
37. DahlbackB(1991)Protein SandC4b-bindingprotein: components involved in the regulation of the protein C anticoagulant system. Thromb Haemost 66:49-61
38. De Meyer GR, Hoylaerts MF, Kockx MM, Yamamoto H, Herman AG, Bult H (1999) Intimal deposition of functional von Willebrand factor in atherogenesis. Arterioscler Thromb Vasc Biol 19:2524-2534 (Pubitemid 29477855)
39. Declerck PJ, De Mol M, Vaughan DE, Collen D (1992) Identification of a conformationally distinct form of plasminogen activator inhibitor-1, acting as a non-inhibitory substrate for tissue-type plasminogen activator. J Biol Chem 267:11693-11696
40. Downing LJ, Wakefield TW, Strieter RM, et al (1997) Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 25:816-827
41. Drake TA, Morrisey JH, Edgington TS (1989) Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 134:1087
42. Eitzman DT, Westrick RJ, Nabel EG, Ginsburg D (2001) Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 95:577-580
43. Elices MJ, Hemler ME (1989) The human integrin VLA-2 is a collagen receptor on some cells and a collagen/laminin receptor on others. Proc Natl Acad Sci U S A 86:9906-9910 (Pubitemid 20030743)
44. Emsley J, Knight CG, Farndale RW, Barnes MJ, Liddington RC (2000) Structural basis of collagen recognition by integrin alpha2beta1. Cell 101:47-56
45. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743-4746 (Pubitemid 19092874)
46. Esmon CT (1993) Molecular events that control the protein C anticoagulant pathway. Thromb Haemost 70:29-35 (Pubitemid 23225446)
47. Esmon CT (1995) Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface. FASEB J 9:946
48. Eto K, Isshiki T, Yamamoto H, Takeshita S, Ochiai M, Yokoyama N, Yoshimoto R, Ikeda Y, Sato T (1999) AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes. Arterioscler Thromb Vasc Biol 19:877-882 (Pubitemid 29177332)
49. Farndale RW, Siljander PR, Onley DJ, Sundaresan P, Knight CG, Barnes MJ (2003) Collagenplatelet interactions: recognition and signalling. Biochem Soc Symp, pp 81-94
50. Ferns GA, Raines EW, Sprugel KH, Motani AS, Reidy MA, Ross R (1991) Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 253:1129-1132 (Pubitemid 21917260)
51. Fleury V, Lijnen HR, Angles Cano E (1993)Mechanism of the enhanced intrinsic activity of single-chain urokinase-type plasminogen activator during ongoing fibrinolysis. J Biol Chem 268:18554-18559 (Pubitemid 23273789)
52. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96:1102-1108 (Pubitemid 27344210)
53. Frebelius S,HedinU, Swedenborg J (1994) Thrombogenicity of the injured vessel wall-role of antithrombin and heparin. Thromb Haemost 71:147-153 (Pubitemid 24023802)
54. Fredholm BB, Abbracchio MP, Burnstock G, Dubyak GR, Harden TK, Jacobson KA, Schwabe U,WilliamsM(1997) Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol Sci 18:79-82 (Pubitemid 27145732)
55. Friedman RJ, StemermanMB,Wenz B,Moore S, Gauldie J, Gent M, Tiell ML, SpaetH(1977) The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits.Smoothmuscle cellproliferationandre- endothelialization. JClin Invest 60:1191-1201 (Pubitemid 8223147)
56. Fukudome K, Esmon CT (1994) Identification, cloning and regulation of a novel endothelial cell protein C/ activated protein C receptor. J Biol Chem 269:26486-26491 (Pubitemid 24328474)
57. Furie B, Furie BC, Flaumenhaft R (2001) A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 86:214-221 (Pubitemid 32666187)
58. Fuster V, Fallon JT, Badimon JJ, Nemerson Y (1997) The unstable atherosclerotic plaque: clinical significance and therapeutic intervention. Thromb Haemost 78:247-255 (Pubitemid 27289249)
59. Gachet C (2001) ADP receptors of platelets and their inhibition. Thromb Haemost 86:222-232 (Pubitemid 32663953)
60. Gailani D, Broze GJ (1991) Factor XI activation in a revised model of blood coagulation. Science 253:909-912 (Pubitemid 21917236)
61. Giesen PLA, Rauch U, Bohrmann B, et al (1999) Blood-borne tissue factor: another view of thrombosis. Proc Natl Acad Sci USA 96:2311-2315 (Pubitemid 29117911)
62. Glazier JJ, Varricchione TR, Ryan TJ, Ruocco NA, Jacobs AK, Faxon DP (1989) Factors predicting recurrent restenosis after percutaneous transluminal coronary balloon angioplasty. Am J Cardiol 63:902-905 (Pubitemid 19105122)
63. Goto S, Sakai H, Goto M, Ono M, Ikeda Y, Handa S, Ruggeri ZM (1999) Enhanced shearinduced platelet aggregation in acute myocardial infarction. Circulation 99:608-613 (Pubitemid 29077358)
64. GouldWR, Silveira JR, Tracy PB (2004)Unique in vivomodifications of coagulation factorV produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem 279:2383-2393 (Pubitemid 38114221)
65. Gurewich V, Pannell R, Louie S, Kelley P, Suddith RL, Greenlee R (1984) Effective and fibrinspecific clot lysis by a zymogen precursor form of urokinase (pro-urokinase). A study in vitro and in two animal species. J Clin Invest 73:1731-1739 (Pubitemid 14084490)
66. GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329:673-682
67. Handa M, Watanabe K, Kawai Y, Kamata T, Koyama T, Nagai H, Ikeda Y (1995) Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder. Thromb Haemost 73:521-528
68. Hathcock JJ, Nemerson Y (2004) Platelet deposition inhibits tissue factor activity: in vitro clots are impermeable to factor Xa. Blood 104:123-127 (Pubitemid 38879847)
69. Hayashi T, Suzuki K (2000) Molecular pathogenesis of Bernard-Soulier syndrome. Semin Thromb Hemost 26:53-59
70. Hechler B, Lenain N, Marchese P, Vial C Heim V, Freund M, Cazenave JP, Cattaneo M, Ruggeri ZM, Evans R, Gachet C (2003) A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo. J Exp Med 198:661-667 (Pubitemid 37040400)
71. Heeb MJ, Mesters RM, Tans G, et al (1993) Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 268:2872-2877 (Pubitemid 23057922)
72. Heeb MJ, Rosing J, Bakker HM, et al (1994) Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci USA 91:2728-2732 (Pubitemid 24139421)
73. Heemskerk JW, Bevers EM, Lindhout T (2002) Platelet activation and blood coagulation. Thromb Haemost 88:186-193 (Pubitemid 34873696)
74. Hindriks G, Ijsseldijk MJ, Sonnenberg A, Sixma JJ, de Groot PG (1992) Platelet adhesion to laminin: role of Ca2+ and Mg2+ ions, shear rate, and platelet membrane glycoproteins. Blood 79:928-935
75. Hoylaerts M, Rijken DC, Lijnen HR, Collen D (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 257:2912-2919 (Pubitemid 12118804)
76. Huang ZF, Higuchi D, Lasky N, Broze Jr. G.J. (1997) Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice. Blood 90:944-951 (Pubitemid 27314126)
77. Huizinga EG, Tsuji S,RomijnRA, SchiphorstME, deGroot PG, Sixma JJ,Gros P (2002) Structures of glycoprotein Ibalpha and its complex with von Willebrand factor A1 domain. Science 297:1176-1179 (Pubitemid 36196734)
78. Humphries MJ (2000) Integrin structure. Biochem Soc Trans 28:311-339
79. Inoue O, Suzuki-Inoue K, Dean WL, Frampton J, Watson SP (2003) Integrin alpha 2 beta 1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2. J Cell Biol 160:769-780 (Pubitemid 36298271)
80. Jaffe EA, Hoyer LW, Nachman RL (1974) Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A 71:1906-1909
81. Jandrot-Perrus M, Busfield S, Lagrue AH, Xiong X, Debili N, Chickering T, Le Couedic JP, Goodearl A, Dussault B, Fraser C, VainchenkerW, Villeval JL (2000) Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily. Blood 96:1798-1807 (Pubitemid 30661064)
82. Jenkins PV, Pasi KJ, Perkins SJ (1998)Molecularmodeling of ligand andmutation sites of the type A domains of human vonWillebrand factor and their relevance to vonWillebrand's disease. Blood 91:2032-2044 (Pubitemid 28185506)
83. Johnston GI, Cook RG,McEver RP (1989) Cloning of GMP-140, a granulemembrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 56:1033-1044 (Pubitemid 19091015)
84. Kadhom N,Wolfrom C, Gautier M, et al (1988) Factor VIII procoagulant antigen in human tissues. Thromb Haemost 59:289-294
85. Kageyama S, Yamamoto H, Nagano M, Arisaka H, Kayahara T, Yoshimoto R (1997) Antithrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human vonWillebrand factor. Br J Pharmacol 122:165-171 (Pubitemid 27376034)
86. Kageyama S, Yamamoto H, Yoshimoto R (2000) Anti-human vonWillebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs. Arterioscler Thromb Vasc Biol 20:2303-2308
87. Kawasaki T, Kaida T, Arnout J, Vermylen J, Hoylaerts MF (1999) A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic. Thromb Haemost 81:306-311 (Pubitemid 29078322)
88. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Farndale RW, Okuma M, Barnes MJ (1998) Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen,whereas CD36, glycoprotein IIb/IIIa, and vonWillebrand factor do not. Blood 91:491-499 (Pubitemid 28053371)
89. Khor SP, McCarthy K, Dupont M, Murray K, Timony G (2000) Pharmacokinetics, pharmacodynamics, allometry, and dose selection for rPSGL-Ig for phase I trial. J Pharmacol Exp Ther 293:618-624 (Pubitemid 30244115)
90. Kim S, Foster C, Lecchi A, Quinton TM, Prosser DM, Jin J, Cattaneo M, Kunapuli SP (2002) Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 99:3629-3636 (Pubitemid 34534532)
91. Knight CG, Morton LF, Onley DJ, Peachey AR, Messent AJ, Smethurst PA, Tuckwell DS, Farndale RW, Barnes MJ (1998) Identification in collagen type I of an integrin alpha2 beta1-binding site containing an essential GER sequence. J Biol Chem 273:33287-33294
92. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, Barnes MJ (2000) The collagen-binding A-domains of integrins alpha(1)β(1) and alpha(2)β(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 275:35-40
93. Konstantinides S, Schäfer F, Thinnes T, LoskutoffDJ (2001) Plasminogen activator inhibitor- 1 and its cofactor vitronectin stabilize arterial thrombi following vascular injury in mice. Circulation 103:576-583 (Pubitemid 32116244)
94. Konstantinides S, Schäfer K,LoskutoffDJ (2002)DoPAI-1 and vitronectinpromote or inhibit neointima formation? The exact role of the fibrinolytic system in vascular remodeling remains uncertain. Arterioscler Thromb Vasc Biol 22:1943-1945 (Pubitemid 36025195)
95. Koppelman SJ, Hackeng TM, Sixma JJ, Bouma BN (1995) Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII. Blood 86:1062-1071
96. Krishnaswamy S, Mann KG, Nesheim ME (1986) The prothrombinase-catalyzed activation of prothrombin proceeds through the intermediate meizothrombin in an ordered, sequential reaction. J Biol Chem 261:8977-8984 (Pubitemid 17205103)
97. Kroll MH, Hellums JD, McIntire LV, Schafer AI, Moake JL (1996) Platelets and shear stress. Blood 88:1525-1541 (Pubitemid 26307046)
98. Kruithof EKO (1988) Plasminogen activator inhibitors-a review. Enzyme 40:113-121
99. Kuiper J, Rijken DC, deMunk GAW, van Berkel TJ (1992) In vivo and in vitro interaction of high and lowmolecular weight single-chain urokinase-type plasminogen activator with rat liver cells. J Biol Chem 267:1589-1595
100. Kuiper J, Van't Hof A, Otter M, Biessen EA, Rijken DC, van Berkel TJ (1996) Interaction of mutants of tissue-type plasminogen activator with liver cells: effect of domain deletions. Biochem J 313:775-780 (Pubitemid 26050807)
101. Lahav J, Wijnen EM, Hess O, Hamaia SW, Griffiths D, Makris M, Knight CG, Essex DW, Farndale RW (2003) Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin alpha2beta1. Blood 102:2085-2092 (Pubitemid 37122384)
102. Lijnen HR, Van Hoef B, Nelles L, Collen D (1990) Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740-Ala) and plasmin-resistant scu-PA (Lys158-Glu). J Biol Chem 265:5232-5236
103. Lijnen HR, Van Hoef B, Lupu F, Moons L, Carmeliet P, Collen D (1998) Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 18:1035-1045. (Pubitemid 28323587)
104. LijnenHR,Arnout J,CollenD(2000a)Vascular endothelial cell function and thrombosis. In: Willerson JT, Cohn JN (eds) Cardiovascular medicine, 2nd edn. Churchill Livingstone, New York, p 1311
105. Lijnen HR, Van Hoef B, Dewerchin M, Collen D (2000b) 2-Antiplasmin gene deficiency in mice does not affect neointima formation after vascular injury. Arterioscler Thromb Vasc Biol 20:1488-1492 (Pubitemid 30353878)
106. Lin MC, Almus-Jacobs F, Chen HH, et al (1997) Shear stress induction of the tissue factor gene. J Clin Invest 99:737-744 (Pubitemid 27097677)
107. Lyons SE, Bruck ME, Bowie EJ, GinsburgD(1992) Impaired intracellular transport produced by a subset of type IIA vonWillebrand disease mutations. J Biol Chem 267:4424-4430
108. MacFarlaneRG(1964)Anenzymecascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498-499
109. Madri JA, Dreyer B, Pitlick FA, Furthmayr H (1980) The collagenous components of the subendothelium. Correlation of structure and function. Lab Invest 43:303-315 (Pubitemid 10008956)
110. Marlar RA, Kleiss AJ, Griffin JH (1982) An alternative pathway of human blood coagulation. Blood 60:1353-1358 (Pubitemid 13211374)
111. Matsushita T,Meyer D, Sadler JE (2000) Localization of vonWillebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanningmutagenesis. J Biol Chem 275:11044-11049 (Pubitemid 30212744)
112. Maynard JR, Heckman CA, Pitlick FA, Nemerson Y (1975) Association of tissue factor activity with the surface of cultured cells. J Clin Invest 55:814-824
113. Melis E, Bonnefoy A, Daenens K, Yamamoto H, Vermylen J, Hoylaerts MF (2004) AlphaIIbbeta3antagonism vs antiadhesive treatment to prevent platelet interactionswith vascular subendothelium. J Thromb Haemost 2:993-1002 (Pubitemid 40185748)
114. Mertens G, Cassiman JJ, van den Berghe H, et al (1992) Cell surface heparin sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties. J Biol Chem 267:20435-20443
115. Moroi M, Jung SM, Okuma M, Shinmyozu K (1989) A patient with platelets deficient in glycoprotein VI that lack both collagen-induced aggregation and adhesion. J Clin Invest 84:1440-1445 (Pubitemid 19272230)
116. Morton LF, Peachey AR, Barnes MJ (1989) Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites. Biochem J 258:157-163 (Pubitemid 19062264)
117. Mottonen J, Strand A, Symersky J, Sweet RM, Danley DE, Geoghegan KF, Gerard RD, Goldsmith EJ (1992) Structural basis of latency in plasminogen activator inhibitor-1. Nature 355:270-273.
118. Naito K, Fujikawa K (1991) Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem 266:7353-7358 (Pubitemid 21906372)
119. Napoleone E, Di Santo A, Lorenzet R (1997) Monocytes upregulate endothelial cell expression of tissue factor: a role for cell-cell contact and cross-talk. Blood 89:541-549 (Pubitemid 27051690)
120. Nemerson Y (1995) Tissue factor: then and now. Thromb Haemost 74:180-184
121. Nesheim M,WangW, BoffaM,Nagashima M,Morser J, Bajzar L (1997) Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 78:386-391 (Pubitemid 27289272)
122. Neuhaus KL, Feuerer W, Jeep-Tebbe S, Niederer W, Vogt A, Tebbe U (1989) Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 14:1566-1569 (Pubitemid 19279061)
123. Nguyen CM, Harrington RA (2003) Glycoprotein IIb/IIIa receptor antagonists: a comparative review of their use in percutaneous coronary intervention. Am J Cardiovasc Drugs 3:423-436 (Pubitemid 38008678)
124. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD (2000) Persistence of platelet thrombus formation in arterioles of mice lacking both vonWillebrand factor and fibrinogen. J Clin Invest 106:385-392 (Pubitemid 30655638)
125. Nieswandt B, Watson SP (2003) Platelet-collagen interaction: is GPVI the central receptor? Blood 102:449-461 (Pubitemid 36841960)
126. Nieuwenhuis HK, Akkerman JW, Houdijk WP, Sixma JJ (1985) Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 318:470-472 (Pubitemid 16195848)
127. Orth K, Madison EL, Gething MJ, Sambrook JF, Herz J (1992) Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1.are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc Natl Acad Sci USA 89:7422-7426
128. Osterud B, Rapaport SI (1977)Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway of human blood coagulation. Proc Natl Acad Sci USA 74:5260-5264
129. Otter M, Zockova P, Kuiper J, van Berkel TJ, Barrett-Bergshoeff MM, RijkenDC (1992) Isolation and characterization of the mannose receptor fromhuman liver potentially involved in the plasma clearance of tissue-type plasminogen activator. Hepatology 16:54-59
130. Oury C, Kuijpers MJ, Toth-Zsamboki E, Bonnefoy A, Danloy S, Vreys I, Feijge MA, De Vos R, Vermylen J, Heemskerk JW, Hoylaerts MF (2003) Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 101:3969-3976 (Pubitemid 36857874)
131. Palabrica T, Lobb R, Furie BC, et al (1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359:948-951
132. Palotie A, Tryggvason K, Peltonen L, Seppa H (1983) Components of subendothelial aorta basement membrane. Immunohistochemical localization and role in cell attachment. Lab Invest 49:362-370 (Pubitemid 13012066)
133. Pietu G, Fressinaud E, Girma JP, Nieuwenhuis HK, Rothschild C, Meyer D (1987) Binding of human von Willebrand factor to collagen and to collagen-stimulated platelets. J Lab Clin Med 109:637-646 (Pubitemid 17093157)
134. Ploplis V, Cornelissen I, Sandoval-Cooper MJ, Weeks L, Noria FA, Castellino FJ (2001) Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1. Am J Pathol 158:107-117 (Pubitemid 32096476)
135. Pratt KP, Shen BW, Takeshima K, Davie EW, Fujikawa K, Stoddard BL (1999) Structure of the C2 domain of human factor VIII at 1.5 A resolution. Nature 402:439-442 (Pubitemid 129544835)
136. PRIMI Trial Study Group (1989) Randomised double-blind trial of recombinant prourokinase against streptokinase in acute myocardial infarction. Lancet 1:863-868
137. Qin F, Dardik H, Pangilinan A, Robinson J, Chuy J, Wengerter K (2001) Remodeling and suppression of intimal hyperplasia of vascular grafts with a distal arteriovenous fistula in a rat model. J Vasc Surg 34:701-706 (Pubitemid 33664922)
138. QuekLS, Pasquet JM,Hers I, CornallR,KnightG,BarnesM,HibbsML,DunnAR, LowellCA, Watson SP (2000) Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway. Blood 96:4246-4253
139. Rajagopalan V, Essex DW, Shapiro SS, Konkle BA (1992) Tumor necrosis factor-alpha modulation of glycoprotein Ib alpha expression in human endothelial and erythroleukemia cells. Blood 80:153-161
140. Rand JH,Wu XX, Potter BJ, Uson RR, Gordon RE (1993) Co-localization of vonWillebrand factor and type VI collagen in human vascular subendothelium.AmJ Pathol 142:843-850 (Pubitemid 24064002)
141. Rapaport SI (1989) Inhibition of factor VIIa/tissue factor-induced blood coagulation with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 73:359-365 (Pubitemid 19060512)
142. Rapaport SI, Rao VM (1995) The tissue factor pathway: how it has become a "Prima Ballerina". Thromb Haemost 74:7-17
143. Rauch U, Bonderman D, Borhman B, et al (2000) Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96:170-175 (Pubitemid 30456467)
144. Rojiani MV, Finlay BB, Gray V, Dedhar S (1991) In vitro interaction of a polypeptide homologous to human Ro/SS-A antigen (calreticulin) with a highly conserved amino acid sequence in the cytoplasmic domain of integrin alpha subunits. Biochemistry 30:9859-9866
145. Romijn RA,Westein E, Bouma B, Schiphorst ME, Sixma JJ, Lenting PJ, Huizinga EG (2003) Mapping the collagen-binding site in the vonWillebrand factor-A3 domain. J Biol Chem 278:15035-15039 (Pubitemid 36799836)
146. Rosenberg RD (1997) Thrombomodulin gene disruption and mutation in mice. Thromb Haemost 78:705-709 (Pubitemid 27289331)
147. Ruggeri ZM (1993) Mechanisms of shear-induced platelet adhesion and aggregation. Thromb Haemost 70:119-123 (Pubitemid 23225462)
148. Ruggeri ZM (1997) Mechanisms initiating platelet thrombus formation. Thromb Haemost 78:611-616 (Pubitemid 27289313)
149. Sadler JE (1998) Biochemistry and genetics of von Willebrand factor. Annu Rev Biochem 67:395-424 (Pubitemid 28411134)
150. Sako D, Chang XJ, Barone KM, et al (1993) Expression cloning of a functional glycoprotein ligand for P-selectin. Cell 75:1179-1186 (Pubitemid 24006114)
151. Savage B, Shattil SJ, Ruggeri ZM (1992) Modulation of platelet function through adhesion receptors. A dual role for glycoprotein IIb-IIIa (integrin alpha IIb beta 3) mediated by fibrinogen and glycoprotein Ib-vonWillebrand factor. J Biol Chem 267:11300-11306
152. Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on vonWillebrand factor. Cell 84:289-297 (Pubitemid 26040846)
153. Schmaier AH, Dahl LD, Hasan AA, et al (1993) Protease nexin-2/amyloid beta-protein precursor. A tight binding inhibitor of coagulation factor IXa. J Clin Invest 92:2540-2545. (Pubitemid 23333565)
154. Shelton-Inloes BB, Titani K, Sadler JE (1986) cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochemistry 25:3164-3171 (Pubitemid 16056959)
155. Shen Y, Romo GM, Dong JF, Schade A, McIntire LV, Kenny D, Whisstock JC, Berndt MC, Lopez JA, Andrews RK (2000) Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex. Blood 95:903-910 (Pubitemid 30062712)
156. Siedlecki CA, Lestini BJ, Kottke-Marchant KK, Eppell SJ, Wilson DL, Marchant RE (1996) Shear-dependent changes in the three-dimensional structure of human vonWillebrand factor. Blood 88:2939-2950 (Pubitemid 26357374)
157. Sims PJ, Wiedmer T (2001) Unraveling the mysteries of phospholipid scrambling. Thromb Haemost 86:266-275 (Pubitemid 32663957)
158. Sixma JJ,PronkA,NievelsteinPN, Zwaginga JJ,HindriksG,TijburgP, BangaJD,DeGrootPG (1991) Platelet adhesion to extracellular matrices of cultured cells. Ann N Y Acad Sci 614:181-192
159. SmethurstPA, Joutsi-Korhonen L,O'ConnorMN,WilsonE, Jennings NS, Garner SF,ZhangY, Knight CG, Dafforn TR, Buckle A, MJ IJ, De Groot PG, Watkins NA, Farndale RW, OuwehandWH(2004) Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103:903-911 (Pubitemid 38129549)
160. Steiner B, Cousot D, Trzeciak A, Gillessen D, Hadvary P (1989) Ca2+-dependent binding of a synthetic Arg-Gly-Asp (RGD) peptide to a single site on the purified platelet glycoprotein IIb-IIIa complex. J Biol Chem 264:13102-13108 (Pubitemid 19194884)
161. Stenflo J, Fernlund P, Egan W, Roepstorff P (1974) Vitamin K dependent modification of glutamic acid residues in prothrombin. Proc Natl Acad Sci USA 71:2730-2733
162. Sugimoto M, Mohri H, McClintock RA, Ruggeri ZM (1991) Identification of discontinuous von Willebrand factor sequences involved in complex formation with botrocetin. A model for the regulation of vonWillebrand factor binding to platelet glycoprotein Ib. J Biol Chem 266:18172-18178 (Pubitemid 21908062)
163. Sugiyama T, Okuma M, Ushikubi F, Sensaki S, Kanaji K, Uchino H (1987) A novel platelet aggregating factor foundin apatientwith defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. Blood 69:1712-1720 (Pubitemid 17091630)
164. Suzuki-Inoue K, Tulasne D, Shen Y, Bori-Sanz T, Inoue O, Jung SM, Moroi M, Andrews RK, Berndt MC,Watson SP (2002) Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J Biol Chem 277:21561-21566 (Pubitemid 34952302)
165. Tait AS, Cranmer SL, Jackson SP, Dawes IW, Chong BH (2001) Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type vonWillebrand disease mutations. Blood 98:1812-1818
166. Tans G, Nicolaes GA, Thomassen MC, et al (1994) Activation of factor V bymeizothrombin. J Biol Chem 269:15969-15972
167. Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Rudiger Schwarz E, von Loewis P, Rosemeyer P, Hopkins G, et al (1995) Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (Saruplase) in acute myocardial infarction: influence on early patency rate (LIMITS Study). JAmColl Cardiol 26:365-573
168. Theilmeier G, Michiels C, Spaepen E, Vreys I, Collen D, Vermylen J, Hoylaerts MF (2002) Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia. Blood 99:4486-4493 (Pubitemid 34627218)
169. Thorsen S (1992) The mechanism of plasminogen activation and the variability of the fibrin effector during tissue-type plasminogen activator-mediated fibrinolysis. Ann NY Acad Sci 667:52-63 (Pubitemid 23061563)
170. Toombs CF, DeGraef GL, Martin JP, et al (1995) Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther 275:941-949 (Pubitemid 26025551)
171. Trumel C, Payrastre B, PlantavidM,Hechler B,Viala C, Presek P,Martinson EA, Cazenave JP, Chap H, Gachet C (1999) A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase. Blood 94:4156-4165
172. Tsuji M Ezumi Y, Arai M, Takayama H (1997) A novel association of Fc receptor gammachain with glycoprotein VI and their co-expression as a collagen receptor in human platelets. J Biol Chem 272:23528-23531 (Pubitemid 27410920)
173. van 't Veer C, Mann KG (1997) Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor II. J Biol Chem 272:4367-4377 (Pubitemid 27078512)
174. Van deWerf F, Vanhaecke J, De Geest H, VerstraeteM, Collen D (1986) Coronary thrombolysis with recombinant single-chain urokinase-type plasminogen activator (rscu-PA) in patients with acute myocardial infarction. Circulation 74:1066-1070 (Pubitemid 17174954)
175. van Heerde WL, de Groot PG, Reutelingsperger CPM (1995) The complexity of the phospholipid binding protein annexin V. Thromb Haemost 73:172-179
176. van Nostrand WE, Schmaier AH, Wagner SL (1992) Potential role of protease nexin- 2/amyloid beta-protein precursor as a cerebral anticoagulant. AnnNY Acad Sci 674:243-252 (Pubitemid 23077412)
177. van Wijnen M, Stam JG, van 't Veer C, et al (1996) The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S. Thromb Haemost 76:397-403 (Pubitemid 26373534)
178. Vlot AJ (1998) Factor VIII and vonWillebrand factor. Thromb Haemost 79:456
179. von dem Borne PAK, Mosnier LO, Tans G, Meijers JCM, Bouma BN (1997) Factor XI activation by meizothrombin: stimulation by phospholipid vesicles containing both phosphatidylserine and phosphatidylethanolamine. Thromb Haemost 78:834-839 (Pubitemid 27366867)
180. Walsh PN (2001) Roles of platelets and factor XI in the initiation of blood coagulation by thrombin. Thromb Haemost 86:75-82 (Pubitemid 32663939)
181. Wang Z, Leisner TM, Parise LV (2003) Platelet alpha2beta1 integrin activation: contribution of ligand internalization and the alpha2-cytoplasmic domain. Blood 102:1307-1315 (Pubitemid 36988037)
182. Weaver WD, Hartmann JR, Anderson JL, Reddy PS, Sobolski JC, Sasahara AA (1994) New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. J Am Coll Cardiol 24:1242-1248 (Pubitemid 24331863)
183. Williamson D, Pikovski I, Cranmer SL,Mangin P, Mistry N, Domagala T, Chehab S, Lanza F, Salem HH, Jackson SP (2002) Interaction between platelet glycoprotein Ibalpha and filamin-1 is essential for glycoprotein Ib/IX receptor anchorage at high shear. J Biol Chem 277:2151-2159 (Pubitemid 34968801)
184. Wiman B, Collen D (1978) Molecular mechanism of physiological fibrinolysis. Nature 272:549-550 (Pubitemid 8312311)
185. WuD, Vanhoorelbeke K, CauwenberghsN,Meiring M, Depraetere H, KotzeHF, DeckmynH (2002) Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons. Blood 99:3623-3628 (Pubitemid 34534531)
186. Wu Y, Asazuma N, Satoh K, Yatomi Y, Takafuta T, Berndt MC, Ozaki Y (2003) Interaction between vonWillebrand factor and glycoprotein Ib activates Src kinase in human platelets: role of phosphoinositide 3-kinase. Blood 101:3469-3476 (Pubitemid 36857929)
187. Wu YP, Vink T, Schiphorst M, van Zanten GH, MJ IJ, de Groot PG, Sixma JJ (2000) Platelet thrombus formation on collagen at high shear rates is mediated by von Willebrand factor-glycoprotein Ib interaction and inhibited by von Willebrand factor-glycoprotein IIb/IIIa interaction. Arterioscler Thromb Vasc Biol 20:1661-1667 (Pubitemid 30353902)
188. Xu Y, Gurusiddappa S, Rich RL, Owens RT, Keene DR, Mayne R, Hook A, Hook M (2000) Multiple binding sites in collagen type I for the integrins alpha1beta1 and alpha2beta1. J Biol Chem 275:38981-38989
189. Yap CL, Hughan SC, Cranmer SL, Nesbitt WS, Rooney MM, Giuliano S, Kulkarni S, Dopheide SM, Yuan Y, Salem HH, Jackson SP (2000) Synergistic adhesive interactions and signaling mechanisms operating between platelet glycoprotein Ib/IX and integrin alpha IIbbeta 3. Studies in human platelets and transfected Chinese hamster ovary cells. J Biol Chem 275:41377-41388 (Pubitemid 32054973)
190. Zheng YM, Liu C, Chen H, Locke D, Ryan JC, Kahn ML (2001 Expression of the platelet receptor GPVI confers signaling via the Fc receptor gamma-chain in response to the snake venom convulxin but not to collagen. J Biol Chem 276:12999-13006